Blue Water Vaccines Announces Exploration of Its Virus-Like Particle (VLP) Platform for Use in Monkeypox Vaccine Candidate

Aug 17, 2022 | Press Releases

CINCINNATI, Aug. 17, 2022 — Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today...

Blue Water Vaccines Reports Second Quarter 2022 Financial Results and Recent Business Highlights

Aug 15, 2022 | Press Releases

Closed private placement in April 2022, with net proceeds of approximately $6.9 millionSigned multiple strategic agreements and collaborations to further vaccine candidate research, development, and manufacturing$22.2 million in cash as of June 30, 2022 CINCINNATI,...

Blue Water Vaccines Reports Second Quarter 2022 Financial Results and Recent Business Highlights

Aug 15, 2022 | Press Releases

Closed private placement in April 2022, with net proceeds of approximately $6.9 millionSigned multiple strategic agreements and collaborations to further vaccine candidate research, development, and manufacturing$22.2 million in cash as of June 30, 2022 CINCINNATI,...

Blue Water Vaccines Announces Closing of $10 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Aug 11, 2022 | Press Releases

CINCINNATI, Aug. 11, 2022 — Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today...

Blue Water Vaccines Announces Closing of $10 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Aug 11, 2022 | Press Releases

CINCINNATI, Aug. 11, 2022 — Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today...

Blue Water Vaccines Announces $10 Million Private Placement Priced At-the-Market under Nasdaq Rules

Aug 9, 2022 | Press Releases

CINCINNATI, Ohio, Aug. 09, 2022 — Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges,...